カテゴリー： 世界, 医療/バイオ, LP Information

世界のアムホテリシンB原薬市場予測 2023年-2029年

【英語タイトル】Global Amphotericin B API Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10322）・商品コード：LP23DC10322
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアムホテリシンB原薬市場」は、過去の販売実績から2022年の世界のアムホテリシンB原薬の総販売量を検討し、2023年から2029年の予測されるアムホテリシンB原薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアムホテリシンB原薬の市場規模を掲載し、XXX百万米ドル規模の世界のアムホテリシンB原薬市場の詳細な分析を提供します。本インサイトレポートは、世界のアムホテリシンB原薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアムホテリシンB原薬市場における各社の独自のポジションをより深く理解するために、アムホテリシンB原薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアムホテリシンB原薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アムホテリシンB原薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アムホテリシンB原薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アムホテリシンB原薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アムホテリシンB原薬の世界主要メーカーとしては、XELLIA PHARMACEUTICALS APS、 GILEAD SCIENCES INC、 ASENCE PHARMA PRIVATE LTD、 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD、 New Asiatic Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアムホテリシンB原薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアムホテリシンB原薬市場をセグメンテーションし、種類別 (純度≥99%、純度<99)、用途別 (注射剤、錠剤)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≥99%、純度<99

・用途別区分：注射剤、錠剤

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアムホテリシンB原薬市場の10年間の市場状況・展望は？
・世界および地域別に見たアムホテリシンB原薬市場成長の要因は何か？
・アムホテリシンB原薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・アムホテリシンB原薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アムホテリシンB原薬の年間販売量2018-2029、地域別現状・将来分析
・アムホテリシンB原薬の種類別セグメント：純度≥99%、純度<99
・アムホテリシンB原薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アムホテリシンB原薬の用途別セグメント：注射剤、錠剤
・アムホテリシンB原薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアムホテリシンB原薬市場
・企業別のグローバルアムホテリシンB原薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアムホテリシンB原薬の年間売上：2018-2023年の売上、市場シェア
・企業別のアムホテリシンB原薬販売価格
・主要企業のアムホテリシンB原薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アムホテリシンB原薬の地域別レビュー
・地域別のアムホテリシンB原薬市場規模2018-2023：年間販売量、売上
・主要国別のアムホテリシンB原薬市場規模2018-2023：年間販売量、売上
・南北アメリカのアムホテリシンB原薬販売の成長
・アジア太平洋のアムホテリシンB原薬販売の成長
・ヨーロッパのアムホテリシンB原薬販売の成長
・中東・アフリカのアムホテリシンB原薬販売の成長

南北アメリカ市場
・南北アメリカの国別のアムホテリシンB原薬販売量、売上（2018-2023）
・南北アメリカのアムホテリシンB原薬の種類別販売量
・南北アメリカのアムホテリシンB原薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアムホテリシンB原薬販売量、売上（2018-2023）
・アジア太平洋のアムホテリシンB原薬の種類別販売量
・アジア太平洋のアムホテリシンB原薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアムホテリシンB原薬販売量、売上（2018-2023）
・ヨーロッパのアムホテリシンB原薬の種類別販売量
・ヨーロッパのアムホテリシンB原薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアムホテリシンB原薬販売量、売上（2018-2023）
・中東・アフリカのアムホテリシンB原薬の種類別販売量
・中東・アフリカのアムホテリシンB原薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アムホテリシンB原薬の製造コスト構造分析
・アムホテリシンB原薬の製造プロセス分析
・アムホテリシンB原薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アムホテリシンB原薬の主要なグローバル販売業者
・アムホテリシンB原薬の主要なグローバル顧客

地域別のアムホテリシンB原薬市場予測レビュー
・地域別のアムホテリシンB原薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アムホテリシンB原薬の種類別市場規模予測
・アムホテリシンB原薬の用途別市場規模予測

主要企業分析
XELLIA PHARMACEUTICALS APS、 GILEAD SCIENCES INC、 ASENCE PHARMA PRIVATE LTD、 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD、 New Asiatic Pharmaceutical
・企業情報
・アムホテリシンB原薬製品
・アムホテリシンB原薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Amphotericin B API market size is projected to grow from US$ 123.3 million in 2022 to US$ 161.6 million in 2029; it is expected to grow at a CAGR of 3.9% from 2023 to 2029.
United States market for Amphotericin B API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amphotericin B API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amphotericin B API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amphotericin B API players cover XELLIA PHARMACEUTICALS APS, GILEAD SCIENCES INC, ASENCE PHARMA PRIVATE LTD, NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD and New Asiatic Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Amphotericin B API Industry Forecast” looks at past sales and reviews total world Amphotericin B API sales in 2022, providing a comprehensive analysis by region and market sector of projected Amphotericin B API sales for 2023 through 2029. With Amphotericin B API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amphotericin B API industry.
This Insight Report provides a comprehensive analysis of the global Amphotericin B API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amphotericin B API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amphotericin B API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amphotericin B API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amphotericin B API.
This report presents a comprehensive overview, market shares, and growth opportunities of Amphotericin B API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity≥99%
Purity<99% Segmentation by application Injection Tablet This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. XELLIA PHARMACEUTICALS APS GILEAD SCIENCES INC ASENCE PHARMA PRIVATE LTD NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD New Asiatic Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Amphotericin B API market? What factors are driving Amphotericin B API market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Amphotericin B API market opportunities vary by end market size? How does Amphotericin B API break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amphotericin B API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amphotericin B API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amphotericin B API by Country/Region, 2018, 2022 & 2029
2.2 Amphotericin B API Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99% 2.3 Amphotericin B API Sales by Type 2.3.1 Global Amphotericin B API Sales Market Share by Type (2018-2023) 2.3.2 Global Amphotericin B API Revenue and Market Share by Type (2018-2023) 2.3.3 Global Amphotericin B API Sale Price by Type (2018-2023) 2.4 Amphotericin B API Segment by Application 2.4.1 Injection 2.4.2 Tablet 2.5 Amphotericin B API Sales by Application 2.5.1 Global Amphotericin B API Sale Market Share by Application (2018-2023) 2.5.2 Global Amphotericin B API Revenue and Market Share by Application (2018-2023) 2.5.3 Global Amphotericin B API Sale Price by Application (2018-2023) 3 Global Amphotericin B API by Company 3.1 Global Amphotericin B API Breakdown Data by Company 3.1.1 Global Amphotericin B API Annual Sales by Company (2018-2023) 3.1.2 Global Amphotericin B API Sales Market Share by Company (2018-2023) 3.2 Global Amphotericin B API Annual Revenue by Company (2018-2023) 3.2.1 Global Amphotericin B API Revenue by Company (2018-2023) 3.2.2 Global Amphotericin B API Revenue Market Share by Company (2018-2023) 3.3 Global Amphotericin B API Sale Price by Company 3.4 Key Manufacturers Amphotericin B API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Amphotericin B API Product Location Distribution 3.4.2 Players Amphotericin B API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Amphotericin B API by Geographic Region 4.1 World Historic Amphotericin B API Market Size by Geographic Region (2018-2023) 4.1.1 Global Amphotericin B API Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Amphotericin B API Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Amphotericin B API Market Size by Country/Region (2018-2023) 4.2.1 Global Amphotericin B API Annual Sales by Country/Region (2018-2023) 4.2.2 Global Amphotericin B API Annual Revenue by Country/Region (2018-2023) 4.3 Americas Amphotericin B API Sales Growth 4.4 APAC Amphotericin B API Sales Growth 4.5 Europe Amphotericin B API Sales Growth 4.6 Middle East & Africa Amphotericin B API Sales Growth 5 Americas 5.1 Americas Amphotericin B API Sales by Country 5.1.1 Americas Amphotericin B API Sales by Country (2018-2023) 5.1.2 Americas Amphotericin B API Revenue by Country (2018-2023) 5.2 Americas Amphotericin B API Sales by Type 5.3 Americas Amphotericin B API Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Amphotericin B API Sales by Region 6.1.1 APAC Amphotericin B API Sales by Region (2018-2023) 6.1.2 APAC Amphotericin B API Revenue by Region (2018-2023) 6.2 APAC Amphotericin B API Sales by Type 6.3 APAC Amphotericin B API Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Amphotericin B API by Country 7.1.1 Europe Amphotericin B API Sales by Country (2018-2023) 7.1.2 Europe Amphotericin B API Revenue by Country (2018-2023) 7.2 Europe Amphotericin B API Sales by Type 7.3 Europe Amphotericin B API Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Amphotericin B API by Country 8.1.1 Middle East & Africa Amphotericin B API Sales by Country (2018-2023) 8.1.2 Middle East & Africa Amphotericin B API Revenue by Country (2018-2023) 8.2 Middle East & Africa Amphotericin B API Sales by Type 8.3 Middle East & Africa Amphotericin B API Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Amphotericin B API 10.3 Manufacturing Process Analysis of Amphotericin B API 10.4 Industry Chain Structure of Amphotericin B API 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Amphotericin B API Distributors 11.3 Amphotericin B API Customer 12 World Forecast Review for Amphotericin B API by Geographic Region 12.1 Global Amphotericin B API Market Size Forecast by Region 12.1.1 Global Amphotericin B API Forecast by Region (2024-2029) 12.1.2 Global Amphotericin B API Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Amphotericin B API Forecast by Type 12.7 Global Amphotericin B API Forecast by Application 13 Key Players Analysis 13.1 XELLIA PHARMACEUTICALS APS 13.1.1 XELLIA PHARMACEUTICALS APS Company Information 13.1.2 XELLIA PHARMACEUTICALS APS Amphotericin B API Product Portfolios and Specifications 13.1.3 XELLIA PHARMACEUTICALS APS Amphotericin B API Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 XELLIA PHARMACEUTICALS APS Main Business Overview 13.1.5 XELLIA PHARMACEUTICALS APS Latest Developments 13.2 GILEAD SCIENCES INC 13.2.1 GILEAD SCIENCES INC Company Information 13.2.2 GILEAD SCIENCES INC Amphotericin B API Product Portfolios and Specifications 13.2.3 GILEAD SCIENCES INC Amphotericin B API Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 GILEAD SCIENCES INC Main Business Overview 13.2.5 GILEAD SCIENCES INC Latest Developments 13.3 ASENCE PHARMA PRIVATE LTD 13.3.1 ASENCE PHARMA PRIVATE LTD Company Information 13.3.2 ASENCE PHARMA PRIVATE LTD Amphotericin B API Product Portfolios and Specifications 13.3.3 ASENCE PHARMA PRIVATE LTD Amphotericin B API Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 ASENCE PHARMA PRIVATE LTD Main Business Overview 13.3.5 ASENCE PHARMA PRIVATE LTD Latest Developments 13.4 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD 13.4.1 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Company Information 13.4.2 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Amphotericin B API Product Portfolios and Specifications 13.4.3 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Amphotericin B API Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Main Business Overview 13.4.5 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Latest Developments 13.5 New Asiatic Pharmaceutical 13.5.1 New Asiatic Pharmaceutical Company Information 13.5.2 New Asiatic Pharmaceutical Amphotericin B API Product Portfolios and Specifications 13.5.3 New Asiatic Pharmaceutical Amphotericin B API Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 New Asiatic Pharmaceutical Main Business Overview 13.5.5 New Asiatic Pharmaceutical Latest Developments 14 Research Findings and Conclusion

List of Tables
Table 1. Amphotericin B API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amphotericin B API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity≥99%
Table 4. Major Players of Purity<99%
Table 5. Global Amphotericin B API Sales by Type (2018-2023) & (Tons)
Table 6. Global Amphotericin B API Sales Market Share by Type (2018-2023)
Table 7. Global Amphotericin B API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Amphotericin B API Revenue Market Share by Type (2018-2023)
Table 9. Global Amphotericin B API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Amphotericin B API Sales by Application (2018-2023) & (Tons)
Table 11. Global Amphotericin B API Sales Market Share by Application (2018-2023)
Table 12. Global Amphotericin B API Revenue by Application (2018-2023)
Table 13. Global Amphotericin B API Revenue Market Share by Application (2018-2023)
Table 14. Global Amphotericin B API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Amphotericin B API Sales by Company (2018-2023) & (Tons)
Table 16. Global Amphotericin B API Sales Market Share by Company (2018-2023)
Table 17. Global Amphotericin B API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Amphotericin B API Revenue Market Share by Company (2018-2023)
Table 19. Global Amphotericin B API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Amphotericin B API Producing Area Distribution and Sales Area
Table 21. Players Amphotericin B API Products Offered
Table 22. Amphotericin B API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Amphotericin B API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Amphotericin B API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Amphotericin B API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Amphotericin B API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Amphotericin B API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Amphotericin B API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Amphotericin B API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Amphotericin B API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Amphotericin B API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Amphotericin B API Sales Market Share by Country (2018-2023)
Table 35. Americas Amphotericin B API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Amphotericin B API Revenue Market Share by Country (2018-2023)
Table 37. Americas Amphotericin B API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Amphotericin B API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Amphotericin B API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Amphotericin B API Sales Market Share by Region (2018-2023)
Table 41. APAC Amphotericin B API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Amphotericin B API Revenue Market Share by Region (2018-2023)
Table 43. APAC Amphotericin B API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Amphotericin B API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Amphotericin B API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Amphotericin B API Sales Market Share by Country (2018-2023)
Table 47. Europe Amphotericin B API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Amphotericin B API Revenue Market Share by Country (2018-2023)
Table 49. Europe Amphotericin B API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Amphotericin B API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Amphotericin B API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Amphotericin B API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Amphotericin B API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Amphotericin B API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amphotericin B API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Amphotericin B API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Amphotericin B API
Table 58. Key Market Challenges & Risks of Amphotericin B API
Table 59. Key Industry Trends of Amphotericin B API
Table 60. Amphotericin B API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Amphotericin B API Distributors List
Table 63. Amphotericin B API Customer List
Table 64. Global Amphotericin B API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Amphotericin B API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Amphotericin B API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Amphotericin B API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Amphotericin B API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Amphotericin B API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Amphotericin B API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Amphotericin B API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Amphotericin B API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Amphotericin B API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Amphotericin B API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Amphotericin B API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Amphotericin B API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Amphotericin B API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. XELLIA PHARMACEUTICALS APS Basic Information, Amphotericin B API Manufacturing Base, Sales Area and Its Competitors
Table 79. XELLIA PHARMACEUTICALS APS Amphotericin B API Product Portfolios and Specifications
Table 80. XELLIA PHARMACEUTICALS APS Amphotericin B API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. XELLIA PHARMACEUTICALS APS Main Business
Table 82. XELLIA PHARMACEUTICALS APS Latest Developments
Table 83. GILEAD SCIENCES INC Basic Information, Amphotericin B API Manufacturing Base, Sales Area and Its Competitors
Table 84. GILEAD SCIENCES INC Amphotericin B API Product Portfolios and Specifications
Table 85. GILEAD SCIENCES INC Amphotericin B API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. GILEAD SCIENCES INC Main Business
Table 87. GILEAD SCIENCES INC Latest Developments
Table 88. ASENCE PHARMA PRIVATE LTD Basic Information, Amphotericin B API Manufacturing Base, Sales Area and Its Competitors
Table 89. ASENCE PHARMA PRIVATE LTD Amphotericin B API Product Portfolios and Specifications
Table 90. ASENCE PHARMA PRIVATE LTD Amphotericin B API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. ASENCE PHARMA PRIVATE LTD Main Business
Table 92. ASENCE PHARMA PRIVATE LTD Latest Developments
Table 93. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Basic Information, Amphotericin B API Manufacturing Base, Sales Area and Its Competitors
Table 94. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Amphotericin B API Product Portfolios and Specifications
Table 95. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Amphotericin B API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Main Business
Table 97. NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD Latest Developments
Table 98. New Asiatic Pharmaceutical Basic Information, Amphotericin B API Manufacturing Base, Sales Area and Its Competitors
Table 99. New Asiatic Pharmaceutical Amphotericin B API Product Portfolios and Specifications
Table 100. New Asiatic Pharmaceutical Amphotericin B API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. New Asiatic Pharmaceutical Main Business
Table 102. New Asiatic Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Amphotericin B API
Figure 2. Amphotericin B API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Amphotericin B API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amphotericin B API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity≥99%
Figure 10. Product Picture of Purity<99%
Figure 11. Global Amphotericin B API Sales Market Share by Type in 2022
Figure 12. Global Amphotericin B API Revenue Market Share by Type (2018-2023)
Figure 13. Amphotericin B API Consumed in Injection
Figure 14. Global Amphotericin B API Market: Injection (2018-2023) & (Tons)
Figure 15. Amphotericin B API Consumed in Tablet
Figure 16. Global Amphotericin B API Market: Tablet (2018-2023) & (Tons)
Figure 17. Global Amphotericin B API Sales Market Share by Application (2022)
Figure 18. Global Amphotericin B API Revenue Market Share by Application in 2022
Figure 19. Amphotericin B API Sales Market by Company in 2022 (Tons)
Figure 20. Global Amphotericin B API Sales Market Share by Company in 2022
Figure 21. Amphotericin B API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Amphotericin B API Revenue Market Share by Company in 2022
Figure 23. Global Amphotericin B API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Amphotericin B API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Amphotericin B API Sales 2018-2023 (Tons)
Figure 26. Americas Amphotericin B API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Amphotericin B API Sales 2018-2023 (Tons)
Figure 28. APAC Amphotericin B API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Amphotericin B API Sales 2018-2023 (Tons)
Figure 30. Europe Amphotericin B API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Amphotericin B API Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Amphotericin B API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Amphotericin B API Sales Market Share by Country in 2022
Figure 34. Americas Amphotericin B API Revenue Market Share by Country in 2022
Figure 35. Americas Amphotericin B API Sales Market Share by Type (2018-2023)
Figure 36. Americas Amphotericin B API Sales Market Share by Application (2018-2023)
Figure 37. United States Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Amphotericin B API Sales Market Share by Region in 2022
Figure 42. APAC Amphotericin B API Revenue Market Share by Regions in 2022
Figure 43. APAC Amphotericin B API Sales Market Share by Type (2018-2023)
Figure 44. APAC Amphotericin B API Sales Market Share by Application (2018-2023)
Figure 45. China Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Amphotericin B API Sales Market Share by Country in 2022
Figure 53. Europe Amphotericin B API Revenue Market Share by Country in 2022
Figure 54. Europe Amphotericin B API Sales Market Share by Type (2018-2023)
Figure 55. Europe Amphotericin B API Sales Market Share by Application (2018-2023)
Figure 56. Germany Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Amphotericin B API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Amphotericin B API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Amphotericin B API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Amphotericin B API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Amphotericin B API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Amphotericin B API in 2022
Figure 71. Manufacturing Process Analysis of Amphotericin B API
Figure 72. Industry Chain Structure of Amphotericin B API
Figure 73. Channels of Distribution
Figure 74. Global Amphotericin B API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Amphotericin B API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Amphotericin B API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Amphotericin B API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Amphotericin B API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Amphotericin B API Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアムホテリシンB原薬市場予測 2023年-2029年] (コード：LP23DC10322)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアムホテリシンB原薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のPVT高純度炭化ケイ素粉末市場予測 2023年-2029年
  • 世界の医薬品用高純度窒素市場予測 2023年-2029年
  • 世界のアメリシウム-243市場予測 2023年-2029年
  • 世界のバーケリウム-249市場予測 2023年-2029年
  • 世界のビスマス-213市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆